Journal Home
Search for

Volume 37, Issue 5, Pages 605-614 (July 2010)


View previous. 10 of 17 View next.

Synthesis, radiofluorination and first evaluation of [18F]fluorophenylsulfonyl- and [18F]fluorophenylsulfinyl-piperidines as serotonin 5-HT2A receptor antagonists for PET

Ute Mühlhausen1, Wiebke Sihver, Johannes ErmertCorresponding Author Informationemail address, Heinz H. Coenen

Received 9 November 2009; received in revised form 4 February 2010; accepted 8 March 2010. published online 26 April 2010.

Abstract 

In psychiatric disorders, 5-HT2A receptors play an important role. In order to study these receptors in vivo by positron emission tomography (PET), there is an increasing interest for subtype selective and high affinity radioligands. Up to now, no optimal radiotracer is available. Thus, 1-(2,4-difluorophenethyl)-4-(4-fluorophenylsulfonyl)piperidine (9), possessing high affinity and sufficient subtype selectivity for 5-HT2A receptors, and 1-(2,4-difluorophenethyl)-4-(4-fluorophenylsulfinyl)piperidine (15) have been 18F-labelled by a nucleophilic one-step reaction. Both radiotracers could be prepared and isolated within 45 min, [18F]9 in a radiochemical yield (RCY) of 34.5±8% and [18F]15 of 9.5±2.5%. The Ki values of 9 and 15 at 5-HT2A receptors towards [3H]ketanserin were determined to be 1.9±0.6 and 198±8 nM, respectively. Autoradiography with [18F]9 and [18F]15 on rat brain sections showed a very high nonspecific binding of >80% for [18F]9 and 30% to 40% nonspecific binding for [18F]15; however, it is still too high in order to compensate for its lower affinity. Even though the affinity of 9 is more promising compared with 15, the high nonspecific binding of both radiofluorinated tracers in rat brain does not recommend those as an in vivo PET imaging agent for serotonin 5-HT2A receptors in humans.

Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany

Corresponding Author InformationCorresponding author. Tel.: +49 2461 613110; fax: +49 2461 612119.

1 Present address: Department of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

PII: S0969-8051(10)00060-0

doi:10.1016/j.nucmedbio.2010.03.003


View previous. 10 of 17 View next.